Menu
Contact

Pipeline

We shape our patient care with a thoughtfully positioned pipeline of high-quality brand and generic products focused on impact.

Central Nervous System

505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Substance Use Disorder

505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Chronic Pain

505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Substance Use Disorder

ANDA

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Central Nervous System

505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Cough & Cold

Multiple 
OTC Monographs

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

GI Relief

OTC Monograph

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Pain Relief

OTC Monograph

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Central Nervous System

505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Central Nervous System

505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Chemopreventative

NCE

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Insomnia

NCE/505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Pain/Inflammation

NCE/505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

CNS

NCE/505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Rare Disease

NCE/505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Available for partnering

Anti-Coagulation

505b2

  • Formulation
  • PreClinical
  • Phase I
    -

    Pilot Clinical
  • Phase II
  • Phase III
    -

    Registration Production
  • Filed
  • Commercial Approval

Active Ingredient: Apixaban

Together, It’s Possible

We’re here to revolutionize drug delivery and bring therapy to life.
Talk to our experts today about getting started.

Talk to us
Contact